Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results

T. Kokame, Gregg; Yeung, Ling; C. K. Lai, J.

doi:10.1136/bjo.2008.150029

Public

Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results

Published in British Journal of Ophthalmology • Sep 1, 2009

Authors:

Gregg T. Kokame

Ling Yeung

J. C. K. Lai

Abstract

AIM: To evaluate the short-term efficacy and safety of monthly intravitreal injections of ranibizumab in patients with polypoidal choroidal vasculopathy (PCV) and active exudation or haemorrhage. METHODS: A prospective, open-label trial of monthly intravitreal ranibizumab (0.5 mg) injections for PCV...

Subject

Medicine

Ranibizumab

Ophthalmology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!